sol-gel.com - SLGL Net Assets per Single Share

Graphic logo of Sol-Gel Technologies (SLGL)

Sol-Gel Technologies (SLGL) profitability is constrained by patent disputes and a reliance on external investments. The book value per share illustrates the margin of safety, where the 14.61 metric confirms the current level. Revenues are based on innovative treatments for rosacea and acne, while management focuses on pipeline development and increasing royalty payments from partners.

Sol-Gel Technologies Ltd (SLGL): Share Book Value from 07/04/2022 to 10/26/2026

sol-gel.com - analytical breakdowns and key metrics (SLGL)

- price and consensus price forecast:
Stock Price Sol-Gel|SLGL - Analyst Target Range
- market capitalization data:
Market Value Sol-Gel Technologies Ltd.|SLGL - Total Company Value
- book capitalization data:
Net Assets per Single Share Sol-Gel Technologies|SLGL - Net Asset Value|Market Capitalization to Book Value Ratio sol-gel.com|SLGL - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Sol-Gel Technologies|SLGL - Long-Term Debt to Capital|Short-Term Debt to Equity Sol-Gel Technologies Ltd.|SLGL - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Sol-Gel Technologies Ltd.
Fundamental company valuation:Sol-Gel - SLGL
Manufactured products of Sol-Gel Technologies Ltd.

The diversification of production capacities and strategic raw material reserves of Sol-Gel Technologies (SLGL) ensure high operational resilience and a stable cash flow. This BVPS chart reflects the current net asset value per share in real-time, allowing investors to determine the fundamental margin of safety and assess the real cost of capital relative to market quotes.

Competitors of Sol-Gel Technologies (SLGL)

Book Value per Share KRYS|APGE: Book Value of One Share|Arcutis Biotherapeutics (ARQT) - Net Assets per Single Share|VCEL (vcel.com) - Net Assets per Single Share|Net Assets per Single Share Oruka Therapeutics ORKA|Share Book Value Sanara|DBV Technologies S.A. (DBVT) - Book Value per Share|Accounting Value of a Share solesence.com (SLSN)|Book Value per Share DERM (Journey Medical Corporation)|fortebiorx.com - Book Value per Share|Net Assets per Single Share Empro Group (EMPG)|AXIL: Accounting Value of a Share|MDCX (Medicus Pharma Limited) - Net Assets per Single Share|Verrica Pharmaceuticals Inc. (VRCA) - Accounting Value per Share|HOTH (Hoth Therapeutics Inc.) - Book Value per Share|Book Value per Share Biofrontera Inc (BFRI)|VYNE Therapeutics (VYNE) - Accounting Value per Share|Accounting Value of a Share SNOA (sonomapharma.com)|Net Assets per Single Share QNRX|Azitra Corporation - Net Assets per Share|Dermata Therapeutics - Net Assets per Single Share|ELAB - Book Value per Share|Revance Therapeutics, Inc. - Book Value per Share